Cargando…
Altered enhancer transcription underlies Huntington’s disease striatal transcriptional signature
Epigenetic and transcriptional alterations are both implicated in Huntington’s disease (HD), a progressive neurodegenerative disease resulting in degeneration of striatal neurons in the brain. However, how impaired epigenetic regulation leads to transcriptional dysregulation in HD is unclear. Here,...
Autores principales: | Le Gras, Stéphanie, Keime, Céline, Anthony, Anne, Lotz, Caroline, De Longprez, Lucie, Brouillet, Emmanuel, Cassel, Jean-Christophe, Boutillier, Anne-Laurence, Merienne, Karine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320509/ https://www.ncbi.nlm.nih.gov/pubmed/28225006 http://dx.doi.org/10.1038/srep42875 |
Ejemplares similares
-
Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017) -
Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington’s disease mice
por: Alcalá-Vida, Rafael, et al.
Publicado: (2021) -
Transcriptional Activation of REST by Sp1 in Huntington's Disease Models
por: Ravache, Myriam, et al.
Publicado: (2010) -
Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator
por: Chatterjee, Snehajyoti, et al.
Publicado: (2018) -
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin
por: Galvan, Laurie, et al.
Publicado: (2018)